Escient Pharmaceuticals Overview
- Year Founded
-
2017
- Status
-
Acquired/Merged
- Employees
-
46
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$754M
Escient Pharmaceuticals General Information
Description
Operator of a therapeutics drugs company intended to address a broad range of neurosensory-inflammatory disorders. The company's platform focuses on offering therapies for neuro-immuno-inflammatory and autoreactive diseases targeting the treatment of mast cell-mediated disorders and cholestatic pruritus, enabling healthcare providers to address treatment options for a broad range of diseases.
Contact Information
Website
www.escientpharma.com(Operating Subsidiary)
Corporate Office
- 10578 Science Center Drive
- Suite 250
- San Diego, CA 92121
- United States
Corporate Office
- 10578 Science Center Drive
- Suite 250
- San Diego, CA 92121
- United States
Escient Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 30-May-2024 | $754M | Completed | Clinical Trials - Phase 2 | ||
| 4. Later Stage VC (Series C) | 28-Nov-2022 | Completed | Clinical Trials - Phase 2 | |||
| 3. Early Stage VC (Series B) | 25-Aug-2020 | Completed | Clinical Trials - Phase 1 | |||
| 2. Early Stage VC (Series A) | 09-May-2018 | $40M | $40M | Completed | Startup | |
| 1. Accelerator/Incubator | 14-Aug-2017 | Completed | Startup |
Escient Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A | 40,456,205 | $0.000100 | $0.08 | $1 | $1 | 1x | $1 | 12.14% |
Escient Pharmaceuticals Comparisons
Industry
Financing
Details
Escient Pharmaceuticals Competitors (42)
One of Escient Pharmaceuticals’s 42 competitors is Blueprint Medicines, a Formerly VC-backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Blueprint Medicines | Formerly VC-backed | Cambridge, MA | ||||
| DICE Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| Centrose | Venture Capital-Backed | Middleton, WI | ||||
| Neuro-Sys | Accelerator/Incubator Backed | Gardanne, France | ||||
| Gilead Sciences | Formerly VC-backed | Foster City, CA |
Escient Pharmaceuticals Patents
Escient Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4499632-A1 | Quinoline derivatives as modulators of mas-related g-protein receptor x2 and related products | Pending | 29-Mar-2023 | ||
| US-20240307394-A1 | Modulators of mas-related g-protein receptor d and related products and methods | Pending | 17-Mar-2023 | ||
| US-20240246980-A1 | Modulators of mas-related g-protein receptor d and related products and methods | Pending | 28-Oct-2022 | ||
| US-20240124415-A1 | Modulators of mas-related g-protein receptor x2 and related products and methods | Active | 30-Mar-2022 | ||
| US-20240059667-A1 | Modulators of mas-related g-protein receptor x2 and related products and methods | Pending | 30-Mar-2022 | C07D401/14 |
Escient Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Escient Pharmaceuticals Former Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 5AM Ventures | Venture Capital | Minority | ||
| Abingworth | Venture Capital | Minority | ||
| Altitude Life Science Ventures | Venture Capital | Minority | ||
| Avalon Ventures | Venture Capital | Minority | ||
| Avego Management | PE/Buyout | Minority |
Escient Pharmaceuticals FAQs
-
When was Escient Pharmaceuticals founded?
Escient Pharmaceuticals was founded in 2017.
-
Where is Escient Pharmaceuticals headquartered?
Escient Pharmaceuticals is headquartered in San Diego, CA.
-
What is the size of Escient Pharmaceuticals?
Escient Pharmaceuticals has 46 total employees.
-
What industry is Escient Pharmaceuticals in?
Escient Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Escient Pharmaceuticals a private or public company?
Escient Pharmaceuticals is a Private company.
-
What is the current valuation of Escient Pharmaceuticals?
The current valuation of Escient Pharmaceuticals is .
-
What is Escient Pharmaceuticals’s current revenue?
The current revenue for Escient Pharmaceuticals is .
-
How much funding has Escient Pharmaceuticals raised over time?
Escient Pharmaceuticals has raised $238M.
-
Who are Escient Pharmaceuticals’s investors?
5AM Ventures, Abingworth, Altitude Life Science Ventures, Avalon Ventures, and Avego Management are 5 of 16 investors who have invested in Escient Pharmaceuticals.
-
Who are Escient Pharmaceuticals’s competitors?
Blueprint Medicines, DICE Therapeutics, Centrose, Neuro-Sys, and Gilead Sciences are some of the 42 competitors of Escient Pharmaceuticals.
-
When was Escient Pharmaceuticals acquired?
Escient Pharmaceuticals was acquired on 30-May-2024.
-
Who acquired Escient Pharmaceuticals?
Escient Pharmaceuticals was acquired by Incyte.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
